Research & Development

Rare cannabinoid discovery at GMP

Although GMP’s goal as an R&D company is to push the boundaries of rare cannabinoid discovery, we are also steadfast producers of common cannabinoids to supply the following customers:

Bulk API Producers of common cannabinoids (Δ8 and Δ9 THC, CBD, CBN, CBG)
13 formulas for the domestic and international Medical market
Contract Manufacturing for 3rd Parties for Nebulizer devices
Tissue Culture of unique cultivars to the medical and recreational market
Our R&D findings combined with our facilities capability to produce and process both our bulk material and nano-formulas is industry leading. Between our LP, NHP and DEL licensed areas, we are built to produce the cannabis medical products that will drive this industry well into the future.”

Dr. Diego Delgado
Chief Medical Officer, GMP